|Bid||1.6400 x 4000|
|Ask||1.6600 x 38800|
|Day's Range||1.5054 - 1.7000|
|52 Week Range||1.2100 - 8.6900|
|Beta (5Y Monthly)||3.04|
|PE Ratio (TTM)||N/A|
|Earnings Date||Sep 26, 2022 - Sep 30, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.09|
Subscribe to Yahoo Finance Plus to view Fair Value for ACB
Trulieve CEO Kim Rivers sits down with Yahoo Finance Live to discuss the cannabis company's latest earnings report and outlook ahead of cannabis regulation bills.
After tumbling on Friday following a lousy earnings report from Canopy Growth (NASDAQ: CGC), shares of fellow Canadian marijuana stocks Tilray (NASDAQ: TLRY) and Aurora Cannabis (NASDAQ: ACB) -- and Canopy Growth, too -- are rebounding sharply today. As of 11:30 a.m. ET, Tilray shares are gaining 10.2%, Aurora is up 12.3%, and Canopy Growth is doing best of all, jumping 16.4%. The opposite is more accurate, with investment bank Piper Sandler coming out with a lower price target on Canopy -- $2.50 per share, down from $3 previously -- and an underweight rating to boot.
Green Thumb Industries Founder and CEO Ben Kovler breaks down the cannabis company's second-quarter earnings beat while diving into the outlook of marijuana legalization and marijuana conviction turnovers in the U.S.